From delayed reactive medical services to evidence-based Predictive, Preventive & Personalised Medicine.
Board of directors
The Board of Directors is a constant for the Association and consists of:

President
Head of 3P Medicine
University Hospital Bonn
Rheinische Friedrich-Wilhelms-Universität Bonn
Germany

Secretary-General
Faculty of Medicine in Pilsen
Charles University
Czech Republic

Dr. Kurt Krapfenbauer
EPMA Vice-President
International Affairs

Dr. Marko Kapalla
Vice-President
European Affairs
Negentropics Systems
Ružomberok
Slovakia

Dr. Pavel Labuda, LL.M. (Cologne-Paris I)
Director responsible for Legal Affairs
Germany
Founder-Members of Directorate
The very first EPMA-event on November 13th, 2008: The juristic protocol has been signed - the Association is born now.
From right to left
First line: Vincenzo Costigliola, Belgium; Olga Golubnitschaja, Germany
Second line: Kurt Krapfenbauer, Austria; Marko Kapalla, Slovakia
Third line: Silvia Mandel, Israel